A Randomised, Placebo-Controlled, Dose-Finding Study Of AZD9668, An Oral Inhibitor of Neutrophil Elastase, in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium

By Vogelmeier Claus   Aquino Teresita O.   O'Brien Christopher D.   Perrett John   Gunawardena Kulasiri A.  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 9, Iss. 2, 2012-03 ,pp. : 111-120

Informa Healthcare

Access to resources Recommend Favorite

Safety of Sputum Induction in Moderate-to-Severe Smoking-Related Chronic Obstructive Pulmonary Disease

By Wilson Andrew   Leigh Richard   Hargreave Frederick   Pizzichini Marcia   Pizzichini Emilio  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 3, Iss. 2, 2006-07 ,pp. : 89-93

Informa Healthcare

Access to resources Recommend Favorite

A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-06 ,pp. : 163-179

Karger

Access to resources Recommend Favorite

Donepezil Treatment of Patients with Severe Alzheimer’s Disease in a Japanese Population: Results from a 24-Week, Double-Blind, Placebo-Controlled, Randomized Trial

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 5, 2008-04 ,pp. : 399-407

Karger

Access to resources Recommend Favorite

Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 30, Iss. 2, 2010-08 ,pp. : 131-146

Karger

Access to resources Recommend Favorite